DarioHealth Corp. (DRIO) Q3 2022 Earnings Call Transcript

Nov. 15, 2022 12:14 PM ETDarioHealth Corp. (DRIO)
SA Transcripts profile picture
SA Transcripts

DarioHealth Corp. (NASDAQ:DRIO) Q3 2022 Results Conference Call November 15, 2022 8:30 AM ET

Company Participants

Glenn Garmont - IR

Erez Raphael - CEO

Rick Anderson - President

Conference Call Participants

Charles Rhyee – Cowen

Rahul Rakhit - LifeSci Capital

David Grossman – Stifel

Ben Haynor - Alliance Global Partners

Chase Knickerbocker - Craig-Hallum


Good day, everyone, and welcome to the DarioHealth Third Quarter 2022 Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Glenn Garmont, Investor Relations. Please go ahead.

Glenn Garmont

Thank you, Joe, and good morning, everybody, and thank you for joining us today for a discussion of DarioHealth's third quarter 2022 financial results. Leading the call today will be Erez Raphael, Chief Executive Officer of DarioHealth and he'll be joined by Rick Anderson, President. After the prepared remarks, we'll open the call for Q&A. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held and recorded on November 15, 2022.

Last evening, we issued a press release announcing our financial results for the third quarter 2022. A copy of the release can be found on the Investor Relations page of the DarioHealth website. Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand or the competitive nature of DarioHealth's industry. Such forward-looking statements and their implications may involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected.

The forward-looking statements discussed on this call are subject to

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.